Jeffrey A. Anderson, VP, Clinical & Regulatory at REVA Medical, Inc. (RVA), sold 10,000 shares at $5.43 ($54K) on 2012-09-13, disclosed to the SEC on 2012-09-14.
Open-market sale of $54k RVA by VP, Clinical & Regulatory. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RVA | SELL | 2012-06-06 | $45K | — | Filing → |
| RVA | SELL | 2012-05-31 | $16K | — | Filing → |